|
Our speakers include:
|
|
|
|
|
Dr Malcolm Skingle,
Director, Academic Liaison, Worldwide Business Development,
Glaxosmithkline |
Karen Huebscher,
Global Head of Business Development and Licensing,
Novartis Vaccines and Diagnostics |
Dr Andrew Wood,
Executive Director, Global External Research and Development,
Eli Lilly |
|
|
|
|
|
Dr Frank Kalkbrenner,
Vice President, Research and Development ,
Boehringer Ingelheim |
Dr Brian Tempest,
Executive Vice Chairman,
Ranbaxy Laboratories |
Dr Raymond Hill, Executive Director and Head, Licensing and External Research, Europe, Merck, Sharp and Dohme |
Click here for the full speaker list >
Capitalise on the future of the life science industry
 Life Science Alliances World offers you the opportunity to be part of a global series of industry-leading Life Science events - with renowned brands such as the World Vaccine Congress Lyon, World Vaccine Congress Washington, bioLOGIC Europe, the European Antibodies Congress the European Stem Cell and Regenerative Medicine Congress and the European BioPharm Scale-Up Congress you will find no better platform to develop your partnering strategy and form future alliances.
|
|
Target your market!
Limited sponsorship opportunities exist for this event.
For full details contact
Chris Comer
Sponsorship Manager
T: +44 (0) 207 827 4157
E: chris.comer@terrapinn.com |
|
|
The conference
 As I’m sure you’re aware, there are an array of partnering events out there. It is critical that you choose the right one. Life Science Alliances World combines a content-driven agenda with unrivalled networking opportunities. Our comprehensive programme covers the issues that matter to you and your business. We aim to be different. Our speakers range from global pharmaceutical giants, niche biotechs, spin-out companies, academics and trust organisations.
We have spent time researching the key issues related to partnering. What problems are companies facing? What is stopping companies from partnering? What critical information do biopharm executives need to facilitate alliances? We conducted a survey of over 20,000 industry leaders to get a better idea of these issues and we will troubleshoot each of them at Life Science Alliances World.
Also ...
The Terrapinn difference
We believe attending a conference should offer more than just the programme delivered in the same old format; it should be an insighful, fun and rewarding experience making your time at the event a memorable one.
 We introduce you to ‘Contact’- a system to enable you to set up meetings before the event. You can search the attendees then email them directly without ever seeing their e-mail address. The first contact is made and you can take it from there. More than just networking; important forms and congress tips can be downloaded and after the event you can even download the white papers and presentations from our world-class speakers.
This is a revolutionary, exciting, quick and non pressurised way to meet fellow delegates in one 50 minute session. These brief meetings are the starting point for conversation and networking throughout the congress. This is where fruitful and long lasting relationships begin.
The congress programme will include several panel sessions. These are chat show style sessions creating an interactive environment rather than a lecture. The panellists are chosen for their views and lively debate is encouraged. This is your chance to interact and put your questions to the panel.
The survey
 Terrapinn is always looking at how we can best address the key issues facing our delegates in today’s dynamic life sciences arena. There is no better way of achieving this than putting bold questions to the people that matter – your audience, our delegates.
We contacted over 20,000 past, present and future delegates in the pharmaceutical and life science industries. We posed a number of searching questions to garner a better understanding of the key issues they are facing regarding their potential partnering and M&A deals in the future.
|
